The Kyvor Genomics Clinical Trials Connector™ allows biopharma companies to quickly identify and review clinical trial opportunities in real-time, matched precisely to each patient’s unique genetic profile. Despite advancements in medical treatments, many patients are eligible for clinical trials, yet only a small percentage participate. Our Clinical Trials Connector is designed to improve enrollment rates by making the process more accessible and efficient for biopharma companies.
How it works
Our platform integrates advanced genomic data analysis and real-time patient-trial matching, ensuring that biopharma companies can identify suitable trial participants quickly and efficiently. This not only accelerates the trial enrollment process but also enhances the likelihood of trial success by ensuring that the right patients are matched with the right trials.
Kyvor’s Matching Criteria:
- Gender
- Age (date-of-birth)
- Tumor type
- Biomarker profile
By aligning the biopharma's requirements such as tumor type, biomarker profile, and therapy, with the clinical trial criteria, we provide a list of patients eligible for enrollment. This benefits biopharma companies by enabling the development of new drugs and offering new treatment options.
Why Choose Kyvor's Clinical Trial Connector
Optimized Patient Matching
Insights from 20,000+ genes, 2,500 cancer-related genes, 50 million RNA reads, and TMB/ MSI, to match patients with trial criteria for better outcomes.
Accelerated Enrollment
Streamline the patient recruitment process, reducing the time and resources needed to enroll participants in clinical trials.
Enhanced Diversity
Ensure representation from diverse patient populations, promoting inclusivity and improving the generalizability of trial results.
Extensive Patient Database
Access our database of 40,000+ patients to streamline recruitment and boost trial success.